Affimed Therapeutics AG, a Heidelberg-based company focused on antibody therapeutics, has appointed Volker Lang as chief business officer. He replaces Gavin D Clark who has founded a consulting company.
Dr. Lang joins Affimed from Scil Technology where he was vice president of corporate development. At Scil Technology, he was responsible for the commercial development of a portfolio of regenerative medicine products.
Source:
Affimed press release, 5 June 2008
Copyright 2008 Evernow Publishing Ltd